INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

306 studies · page 9 of 13

2015 / Metaepidemiological study / network meta-analysis

Exercise and drug interventions showed largely similar mortality outcomes, though exercise was more effective in stroke and diuretics better in heart failure.

Researchers performed a network meta-analysis of 16 meta-analyses plus three recent trials (305 RCTs total, 339,274 participants) comparing exercise and drug interventions on mortality across four conditions. No statistically detectable differences appeared between exercise and drug interventions in coronary heart disease secondary prevention or prediabetes. Exercise was more effective than anticoagulants (OR 0.09, 95% CrI 0.01 to 0.70) and antiplatelets (OR 0.10, 0.01 to 0.62) for stroke rehabilitation, whereas diuretics outperformed exercise in heart failure (exercise v diuretics OR 4.11, 1.17 to 24.76). Authors noted existing randomized trial evidence on exercise interventions remains limited in quantity.

Naci H, Ioannidis JP Br J Sports Med, 2015. PMID 26476429

2015 / Meta-analysis of prospective cohorts

Night-shift work is linked to increased breast cancer and cardiovascular mortality risks

A meta-analysis of 16 prospective cohort studies including 2,020,641 participants examined night-shift work in relation to health outcomes. An increase in night-shift work was associated with incident breast cancer (RR 1.057, 95% CI 1.014-1.102) and cardiovascular death (RR 1.027, 95% CI 1.001-1.053). Longer duration showed higher breast cancer associations, reaching an RR of 1.088 (95% CI 1.012-1.169) for over 20 years, whereas all-cause death was not significantly associated (RR 1.253, 95% CI 0.786-1.997).

Shows an association, not proof of cause and effect.

Lin X, Chen W, Wei F, et al. Sleep Med, 2015. PMID 26498240

2015 / Systematic review and meta-analysis of controlled intervention trials

Tree nut intake significantly lowers total cholesterol, LDL cholesterol, apolipoprotein B, and triglycerides, driven mainly by dose rather than nut type.

A systematic review and meta-analysis of 61 controlled intervention trials (n = 2582, durations 3 to 26 weeks) evaluated the effects of tree nuts on cardiovascular risk markers. Per 1-oz (28.4 g) serving per day, nut intake lowered total cholesterol (-4.7 mg/dL; 95% CI: -5.3, -4.0 mg/dL), LDL cholesterol (-4.8 mg/dL; 95% CI: -5.5, -4.2 mg/dL), ApoB (-3.7 mg/dL; 95% CI: -5.2, -2.3 mg/dL), and triglycerides (-2.2 mg/dL; 95% CI: -3.8, -0.5 mg/dL), with no significant effects on other outcomes. The dose-response for total and LDL cholesterol was nonlinear (P-nonlinearity < 0.001 each), showing stronger effects at ≥60 g/d. ApoB reductions were stronger in populations with type 2 diabetes (-11.5 mg/dL) than in healthy participants (-2.5 mg/dL; P-heterogeneity = 0.015).

Del Gobbo LC, Falk MC, Feldman R, et al. Am J Clin Nutr, 2015. PMID 26561616

2015 / Systematic review and meta-analysis

Oat intake significantly reduced HbA1c, fasting blood glucose, total cholesterol, and LDL-C in patients with type 2 diabetes.

A systematic review and meta-analysis of 14 controlled trials and two uncontrolled observational studies assessed the effects of oat intake in diabetic patients. Compared with controls, oat intake significantly reduced HbA1c (MD, -0.42%; 95% CI, -0.61% to -0.23%), fasting blood glucose (MD, -0.39 mmol/L; 95% CI, -0.58 to -0.19 mmol/L), total cholesterol (MD, -0.49 mmol/L; 95% CI, -0.86 to -0.12 mmol/L), and LDL-C (MD, -0.29 mmol/L; 95% CI, -0.48 to -0.09 mmol/L). Oatmeal also significantly reduced acute postprandial glucose and insulin responses compared with control meals. The authors noted that further studies on type 1 diabetes and safety are needed.

Hou Q, Li Y, Li L, et al. Nutrients, 2015. PMID 26690472

2014 / Meta-analysis of prospective cohort studies

Higher intake of heme iron was associated with elevated coronary heart disease risk.

A meta-analysis of six prospective studies evaluated 131,553 participants and 2,459 coronary heart disease cases. Higher heme iron intake was linked to a 31% greater risk of coronary heart disease compared with lower intake (RR 1.31, 95% CI 1.04 to 1.67). In dose-response analysis, each additional 1 mg/day of heme iron was associated with a 27% increase in risk (RR 1.27, 95% CI 1.10 to 1.47).

Shows an association, not proof of cause and effect.

Yang W, Li B, Dong X, et al. Eur J Nutr, 2014. PMID 23708150

2014 / Systematic review and meta-analysis of controlled feeding trials

Dietary pulses exchanged isocalorically for other foods significantly reduced systolic and mean arterial blood pressure in controlled feeding trials.

A systematic review and meta-analysis evaluated 8 isocaloric controlled feeding trials (n = 554 participants with and without hypertension) of at least 3 weeks duration to assess the effect of dietary pulses on blood pressure. When exchanged isocalorically for other foods, dietary pulses significantly lowered systolic blood pressure (MD = -2.25 mm Hg, 95% CI: -4.22 to -0.28, P = 0.03) and mean arterial blood pressure (MD = -0.75 mm Hg, 95% CI: -1.44 to -0.06, P = 0.03). Diastolic blood pressure was non-significantly lowered (MD = -0.71 mm Hg, 95% CI: -1.74 to 0.31, P = 0.17). Significant heterogeneity was observed for all outcomes.

Jayalath VH, de Souza RJ, Sievenpiper JL, et al. Am J Hypertens, 2014. PMID 24014659

2014 / Meta-analysis of prospective cohorts

Heme iron intake is associated with higher coronary heart disease incidence in cohorts

In a meta-analysis of 21 prospective studies with 292,454 participants, dietary heme iron was linked to higher coronary heart disease incidence (RR 1.57; 95% CI, 1.28 to 1.94), whereas total iron showed an inverse relationship (RR 0.85; 95% CI, 0.73 to 0.999). Neither intake was significantly associated with coronary heart disease mortality. Transferrin saturation was inversely associated with both incidence (RR 0.76; 95% CI, 0.66 to 0.88) and mortality (RR 0.85; 95% CI, 0.73 to 0.99).

Shows an association, not proof of cause and effect.

Hunnicutt J, He K, Xun P J Nutr, 2014. PMID 24401818

2014 / Meta-analysis of prospective cohort studies

Greater Mediterranean diet adherence is linked to lower mortality and chronic disease risk.

In an updated meta-analysis encompassing 4,172,412 individuals, researchers evaluated how Mediterranean diet adherence related to clinical outcomes. A two-point increase in adherence score was linked to an 8% lower risk of all-cause mortality (RR 0.92, 95% CI 0.91 to 0.93). It was also linked to a 10% lower cardiovascular disease risk (RR 0.90, 95% CI 0.87 to 0.92) and a 4% lower risk of neoplastic disease (RR 0.96, 95% CI 0.95 to 0.97).

Shows an association, not proof of cause and effect.

NANO counterpoint →

Sofi F, Macchi C, Abbate R, et al. Public Health Nutr, 2014. PMID 24476641

2014 / Pooled analysis of four 21-day intervention studies

A pooled analysis showed the Ma-Pi 2 macrobiotic diet reduced glycemia, serum lipids, uremia, and cardiovascular risk in adults with type 2 diabetes.

A pooled analysis evaluated data from four 21-day intervention studies investigating the Ma-Pi 2 macrobiotic diet in adults with type 2 diabetes across Cuba, China, Ghana, and Italy. All measured biochemical, body composition, and blood pressure indicators showed significant changes (p < 0.001), most displaying high or very high effect sizes. The global effect sizes were 1.96 in Italy, 1.79 in China, 1.38 in Cuba, and 0.98 in Ghana. The diet significantly reduced glycemia, serum lipids, uremia, and cardiovascular risk, pointing to the need for further clinical studies.

Porrata-Maury C, Hernández-Triana M, Ruiz-Álvarez V, et al. Diabetes Metab Res Rev, 2014. PMID 24532293

2014 / Systematic review and meta-analysis

Vegetarian diets were linked to lower systolic and diastolic blood pressure in both clinical trials and observational studies.

A systematic review and meta-analysis of 7 controlled clinical trials (311 participants) and 32 observational studies (21,604 participants) evaluated the relationship between vegetarian diets and blood pressure. In controlled trials, vegetarian diets were associated with reductions in mean systolic BP (-4.8 mm Hg; 95% CI, -6.6 to -3.1) and diastolic BP (-2.2 mm Hg; 95% CI, -3.5 to -1.0) compared with omnivorous diets. In observational studies, vegetarian diets were associated with lower mean systolic BP (-6.9 mm Hg; 95% CI, -9.1 to -4.7) and diastolic BP (-4.7 mm Hg; 95% CI, -6.3 to -3.1).

Yokoyama Y, Nishimura K, Barnard ND, et al. JAMA Intern Med, 2014. PMID 24566947

2014 / Meta-analysis

Both low and high sodium intakes are linked to higher mortality.

A meta-analysis evaluated 23 cohort studies and two follow-up studies of trials (n = 274,683) to examine sodium intake and health outcomes. Compared with low sodium intake, usual sodium intake was associated with lower all-cause mortality (HR 0.91, 95% CI 0.82-0.99) and cardiovascular events (HR 0.90, 95% CI 0.82-0.99). High intake was linked to higher all-cause mortality (HR 1.16, 95% CI 1.03-1.30) than usual intake, supporting a U-shaped association.

Graudal N, Jürgens G, Baslund B, et al. Am J Hypertens, 2014. PMID 24651634

2014 / Systematic review and meta-analysis of cohort studies and randomized controlled trials

Vitamin D3 supplementation reduced all-cause mortality, while circulating vitamin D was inversely linked to deaths.

In an analysis of 73 observational cohorts with 849,412 adults, lowest versus highest circulating 25-hydroxyvitamin D was associated with higher cardiovascular mortality (RR 1.35; 95% CI: 1.13-1.61) and all-cause mortality (RR 1.35; 95% CI: 1.22-1.49). Across 22 randomized trials with 30,716 participants, vitamin D3 supplementation reduced all-cause mortality (RR 0.89; 95% CI: 0.80-0.99), whereas vitamin D2 did not show a clear benefit (RR 1.04; 95% CI: 0.97-1.11).

Chowdhury R, Kunutsor S, Vitezova A, et al. BMJ, 2014. PMID 24690623

2014 / Systematic review and meta-analysis of randomized controlled trials

Diets emphasizing dietary pulse intake significantly reduced LDL cholesterol levels compared with control diets.

A systematic review and meta-analysis of 26 randomized controlled trials (n = 1037) of at least 3 weeks' duration evaluated the effect of dietary pulses versus isocaloric control diets on lipid targets. Diets emphasizing dietary pulses at a median dose of 130 g/d significantly lowered LDL cholesterol (mean difference -0.17 mmol/L, 95% CI -0.25 to -0.09 mmol/L). No treatment effects were observed for apolipoprotein B or non-HDL cholesterol. The authors noted that trials of longer duration and higher quality are needed to verify these results.

Ha V, Sievenpiper JL, de Souza RJ, et al. CMAJ, 2014. PMID 24710915

2014 / Meta-analysis of randomized controlled trials

Plant sterols and stanols lower LDL cholesterol across intakes up to 3 g/d.

A meta-analysis of 124 randomized controlled studies evaluated plant sterols and stanols across 201 strata, with average intake of 2.1 g/d (range 0.2-9.0 g/d). Daily intakes of 0.6 to 3.3 g/d reduced LDL cholesterol by an average of 6% to 12%. Both sterols and stanols exhibited comparable dose-response patterns, with reductions continuing to rise up to approximately 3 g/d.

Ras RT, Geleijnse JM, Trautwein EA Br J Nutr, 2014. PMID 24780090

2014 / Meta-analysis of prospective cohorts

Higher dietary potassium intake was linked to a lower risk of stroke

Investigators updated a meta-analysis evaluating the link between dietary potassium consumption and cerebrovascular events across 14 prospective cohorts. Comparing extreme intake groups among 333,250 participants with 10,659 recorded incidents showed that higher intake was inversely associated with stroke risk (relative risk 0.80; 95% CI: 0.72 to 0.90). The authors concluded that these findings support guidelines encouraging the consumption of potassium-rich foods.

Shows an association, not proof of cause and effect.

D'Elia L, Iannotta C, Sabino P, et al. Nutr Metab Cardiovasc Dis, 2014. PMID 24780514

2014 / Meta-analysis of prospective cohort studies

Higher fruit and vegetable intake was linked to lower risk of stroke

A meta-analysis of 20 prospective cohort studies including 760,629 participants and 16,981 stroke events evaluated dietary intake. The highest category of total fruit and vegetable consumption was associated with lower stroke risk (multivariable RR 0.79; 95% CI, 0.75-0.84), with reductions seen for fruits (RR 0.77; 95% CI, 0.71-0.84) and vegetables (RR 0.86; 95% CI, 0.79-0.93). Stroke risk was lower by 32% and 11% per 200 g daily increase of fruits and vegetables, respectively.

Shows an association, not proof of cause and effect.

Hu D, Huang J, Wang Y, et al. Stroke, 2014. PMID 24811336

2014 / Meta-analysis of prospective cohorts

Nut intake was inversely associated with ischemic heart disease, CVD, and mortality.

A meta-analysis analyzed 31 reports from 18 prospective studies to assess nut consumption and disease risk. Per daily serving, multivariable-adjusted pooled relative risks were 0.72 (95% CI: 0.64, 0.81) for ischemic heart disease, 0.71 (95% CI: 0.59, 0.85) for cardiovascular disease, and 0.83 (95% CI: 0.76, 0.91) for all-cause mortality. Associations with type 2 diabetes were attenuated after adjusting for body mass index, and stroke was not significantly associated.

Shows an association, not proof of cause and effect.

Luo C, Zhang Y, Ding Y, et al. Am J Clin Nutr, 2014. PMID 24847854

2014 / Meta-analysis of prospective cohorts

Higher dietary protein consumption is linked to a lower risk of stroke.

A meta-analysis of seven prospective cohort studies evaluated dietary protein intake and stroke risk among 254,489 individuals. Comparing the highest to lowest categories of protein intake yielded a pooled relative risk of stroke of 0.80 (95% CI, 0.66 to 0.99). In dose-response evaluation, every 20-g/d increase in protein intake was linked to a 26% lower risk, with animal protein intake showing an RR of 0.71 (95% CI, 0.50 to 0.99).

Shows an association, not proof of cause and effect.

NANO counterpoint →

Zhang Z, Xu G, Yang F, et al. Neurology, 2014. PMID 24920855

2014 / Mendelian randomisation meta-analysis

A genetic variant linked to lower alcohol consumption was associated with lower risk of coronary heart disease and a more favourable cardiovascular profile.

A Mendelian randomisation meta-analysis evaluated 261,991 individuals of European descent across 56 epidemiological studies. Carriers of the ADH1B rs1229984 A-allele consumed 17.2% fewer units of alcohol weekly (95% CI 15.6% to 18.9%) and had lower odds of coronary heart disease (OR 0.90, 95% CI 0.84 to 0.96) and ischaemic stroke (OR 0.83, 95% CI 0.72 to 0.95), with no association identified with combined stroke subtypes. Carriers also had lower systolic blood pressure (-0.88 mm Hg), interleukin-6 levels (-5.2%), waist circumference (-0.3 cm), and body mass index (-0.17 kg/m²).

Shows an association, not proof of cause and effect.

Holmes MV, Dale CE, Zuccolo L, et al. BMJ, 2014. PMID 25011450

2014 / Systematic review and meta-analysis

Adherence to the Mediterranean diet is associated with lower stroke risk.

A systematic review and updated meta-analysis evaluated adherence to dietary patterns and stroke incidence. A re-meta-analysis of 195,875 individuals indicated that higher adherence to the Mediterranean diet was associated with reduced stroke incidence (pooled relative risk 0.68, 95% CI 0.58-0.79). Healthy dietary patterns like DASH and plant-based diets were generally associated with lower stroke risk, while evidence for westernized diets was limited.

NANO counterpoint →

Kontogianni MD, Panagiotakos DB Maturitas, 2014. PMID 25042875

2014 / Systematic review and dose-response meta-analysis

Higher fruit and vegetable intake is linked to reduced all-cause mortality.

A meta-analysis examined 16 prospective cohort studies comprising 833,234 individuals with 56,423 deaths recorded over 4.6 to 26 years. Each additional daily serving of fruits and vegetables was linked to a lower risk of all-cause mortality (pooled HR 0.95, 95% CI, 0.92 to 0.98) and cardiovascular mortality (HR 0.96, 95% CI, 0.92 to 0.99), plateauing around five daily servings. No appreciable association was observed between fruit and vegetable intake and cancer mortality.

Wang X, Ouyang Y, Liu J, et al. BMJ, 2014. PMID 25073782

2014 / Systematic review and meta-analysis of observational studies

A vegetarian diet was associated with modest cardiovascular benefits, driven largely by Seventh Day Adventist studies, with no clear total mortality reduction.

A systematic review and random effects meta-analysis of 8 observational studies evaluated 183,321 participants comparing vegetarian diets to non-vegetarian controls or the general population. Seventh Day Adventist (SDA) cohorts showed larger associations than non-SDA cohorts for death (RR 0.68, 95% CI 0.45-1.02 vs RR 1.04, 95% CI 0.98-1.10), IHD (RR 0.60, 95% CI 0.43-0.80 vs RR 0.84, 95% CI 0.74-0.96), and cerebrovascular disease (RR 0.71, 95% CI 0.41-1.20 vs RR 1.05, 95% CI 0.89-1.24). Significant heterogeneity was present across analyses, particularly among SDA studies. Sex-specific analyses showed IHD was significantly lower in both genders, while risk of death and cerebrovascular disease was significantly reduced only in men.

Shows an association, not proof of cause and effect.

Kwok CS, Umar S, Myint PK, et al. Int J Cardiol, 2014. PMID 25149402

2014 / Dose-response meta-analysis of prospective studies

Coffee intake was inversely associated with all-cause and cardiovascular disease mortality.

A dose-response meta-analysis of 21 prospective studies with 997,464 participants and 121,915 deaths examined coffee intake and mortality. Nonlinear associations emerged, showing peak risk reductions at 4 cups daily for all-cause mortality (16%, 95% CI: 13, 18) and 3 cups daily for cardiovascular mortality (21%, 95% CI: 16, 26). Coffee consumption was not associated with cancer mortality.

Shows an association, not proof of cause and effect.

Crippa A, Discacciati A, Larsson SC, et al. Am J Epidemiol, 2014. PMID 25156996

2014 / Meta-analysis of randomized controlled clinical trials

Garlic powder supplementation significantly reduced total cholesterol, LDL-C, fasting blood glucose, and blood pressure in randomized clinical trials.

A meta-analysis evaluated randomized controlled trials investigating the effects of garlic powder intake on cardiovascular disease risk factors. Garlic powder intake significantly reduced total cholesterol by -0.41 mmol/L (-15.83 mg/dL) and LDL-C by -0.21 mmol/L (-8.11 mg/dL). It also lowered fasting blood glucose by -0.96 mmol/L (-17.30 mg/dL), systolic blood pressure by -4.34 mmHg, and diastolic blood pressure by -2.36 mmHg.

Kwak JS, Kim JY, Paek JE, et al. Nutr Res Pract, 2014. PMID 25489404